VIVXF (Avivagen) Inventories, Finished Goods: $0.58 Mil (As of Jul. 2023)


What is Avivagen Inventories, Finished Goods?

Avivagen VIVXF -99.00% Inventories, Finished Goods is $0.58 Mil as of Jul. 2023.

Avivagen's quarterly finished goods declined from Jan. 2023 ($0.62 Mil) to Apr. 2023 ($0.58 Mil) but then increased from Apr. 2023 ($0.58 Mil) to Jul. 2023 ($0.58 Mil).

Avivagen's annual finished goods increased from Oct. 2020 ($0.30 Mil) to Oct. 2021 ($0.98 Mil) but then declined from Oct. 2021 ($0.98 Mil) to Oct. 2022 ($0.74 Mil).

Avivagen Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Avivagen's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avivagen Inventories, Finished Goods Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.09 0.30 0.98 0.74

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 0.74 0.62 0.58 0.58

Avivagen Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $0.58 Mil mean?
Avivagen (VIVXF) has a Inventories, Finished Goods of $0.58 Mil as of Jul. 2023. Finished goods are inventory items that are complete and ready to be sold. View historical data on Avivagen and its competitors.
Is Avivagen's Inventories, Finished Goods too high?
Avivagen's current Inventories, Finished Goods is $0.58 Mil.
How does Avivagen's Inventories, Finished Goods compare to DMKPQ and MJNE?
Avivagen's Inventories, Finished Goods of $0.58 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Avivagen and its competitors. Avivagen's current Inventories, Finished Goods is $0.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avivagen stock overvalued right now?
Avivagen (VIVXF) has a current Inventories, Finished Goods of $0.58 Mil. The current Inventories, Finished Goods is $0.58 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Avivagen (VIVXF), the current Inventories, Finished Goods is $0.58 Mil as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avivagen Business Description

Address 100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc OxC-beta technology is derived from Avivagen discoveries about Beta-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxCbeta Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. Avivagen's OxC-beta Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters.